These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8638441)

  • 41. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
    Brière J
    Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute myelofibrosis: report of a case and review of current literature.
    Marino GG
    J Am Osteopath Assoc; 1989 Oct; 89(10):1323-6, 1329. PubMed ID: 2681093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Megakaryocytic myelosis--cause of "idiopathic" thrombocythemia].
    Burkhardt R; Kronseder A
    Fortschr Med; 1977 May; 95(19):1261-6. PubMed ID: 863367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute myelofibrosis in children: report on two cases.
    Maj JS; Rosłan K; Fic-Sikorska B
    Acta Haematol Pol; 1996; 27(1):79-84. PubMed ID: 8629448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic studies in the evaluation of myeloproliferative neoplasms.
    Caponetti GC; Bagg A
    Semin Hematol; 2019 Jan; 56(1):7-14. PubMed ID: 30573049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Investigation and management of patients presenting with thrombocytosis].
    Cheminant M; Delarue R
    Rev Med Interne; 2013 Aug; 34(8):465-71. PubMed ID: 23498669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombocytosis and central nervous system involvement in a case of canine acute megakaryoblastic leukemia.
    Rochel D; Abadie J; Robveille C; Déqueant B; Dagher E; Roux F; Jaillardon L
    Vet Clin Pathol; 2018 Sep; 47(3):363-367. PubMed ID: 30024652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myeloproliferative disorders terminating in acute micromegakaryoblastic leukaemia.
    Efrati P; Nir E; Yaari A; Berrebi A; Kaplan H; Dvilanski A
    Br J Haematol; 1979 Sep; 43(1):79-86. PubMed ID: 389275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [On megakaryocytic leukemias and their relation to osteomyelosclerosis].
    KIROV I; SHUBAROV K; VYKLINOV I
    Probl Gematol Pereliv Krovi; 1962 Mar; 7():15-9. PubMed ID: 14456327
    [No Abstract]   [Full Text] [Related]  

  • 52. Chronic myeloproliferative disorders (CMPD).
    Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
    Pathol Res Pract; 1984 Nov; 179(2):131-86. PubMed ID: 6395125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute megakaryocytic myelosis preceded by myelodysplasia. Report of a case and review of the literature.
    Fohlmeister I; Stratmann F; Höck A; Reis HE
    Haematologia (Budap); 1986; 19(2):151-60. PubMed ID: 3758840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Chronic myeloproliferative diseases].
    Sréter L
    Orv Hetil; 1998 Jul; 139(30):1779-83. PubMed ID: 9718944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Essential thrombocytosis].
    Van Camp G
    Acta Clin Belg; 1989; 44(1):31-6. PubMed ID: 2763782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Essential thrombocythemia with myelofibrosis transformed into acute myeloid leukemia with der(1;15)(q10;q10): case report and literature review.
    Charafeddine KM; Mahfouz RA; Zaatari GS; Ibrahim GY; Muwakkit SA; Najm ND; Farra CG
    Cancer Genet Cytogenet; 2010 Jul; 200(1):28-33. PubMed ID: 20513531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Beta-thromboglobulin and platelet factor 4 in a follow-up of acute myelofibrosis (megakaryoblastic leukemia)].
    Palomera Bernal L; García Díez I
    Med Clin (Barc); 1990 Jun; 95(1):21-4. PubMed ID: 2146451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A myeloproliferative disorder may hide another one.
    Laibe S; Tadrist Z; Arnoulet C; Sainty D; Mozziconacci MJ
    Leuk Res; 2009 Aug; 33(8):1133-6. PubMed ID: 19250672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute myelogenous leukemia with megakaryocytic myelosis.
    Habib A; Lee H; Chan M
    Am J Clin Pathol; 1980 Nov; 74(5):705-9. PubMed ID: 6934691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.